The a2 Milk Company felt the immediate impact, with its shares falling more than 10% following the data release and triggering a brief trading halt on the ASX. On the NZX, the stock dropped from NZ$10.87 to NZ$9.80 in a single session and hovered near NZ$9.50 for much of the week, erasing roughly NZ$900 million in market capitalisation.

UBS analyst Marcus Curley highlighted that marriage registrations rose 20% year-on-year between April and September, suggesting a meaningful recovery in births during 2026. He also noted the likelihood of expanded financial support from Chinese authorities to encourage family formation. Jarden analysts projected newborn numbers in the low 8 million range for 2026, aligning with recent marriage trends, while stressing that long-term demographic pressures continue to drive structural decline in the infant milk formula category.

Forsyth Barr analysts argued that the market reaction to a2’s share price may overlook timing effects, as about two-thirds of its revenue comes from Stage 3 products for children aged 12 months and older. They revised their 2026 birth forecast down to 8.2 million from 8.6 million but noted that marriage data through the first three quarters was still up 9% year-on-year, historically a reliable indicator of future births, even as over half of Chinese births are now second-born or later children.